Rigel Pharmaceuticals, Inc. (RIGL)
NASDAQ: RIGL · Real-Time Price · USD
29.54
+0.14 (0.48%)
At close: May 4, 2026, 4:00 PM EDT
29.15
-0.39 (-1.32%)
After-hours: May 4, 2026, 7:58 PM EDT
Rigel Pharmaceuticals Employees
As of December 31, 2025, Rigel Pharmaceuticals had 174 total employees, including 172 full-time and 2 part-time employees. The number of employees increased by 10 or 6.10% compared to the previous year.
Employees
174
Change (1Y)
10
Growth (1Y)
6.10%
Revenue / Employee
$1,691,276
Profits / Employee
$2,109,333
Market Cap
545.90M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 174 | 10 | 6.10% | 172 | 2 |
| Dec 31, 2024 | 164 | 17 | 11.56% | 162 | 2 |
| Dec 31, 2023 | 147 | -8 | -5.16% | 147 | 0 |
| Dec 31, 2022 | 155 | -10 | -6.06% | 155 | 0 |
| Dec 31, 2021 | 165 | -4 | -2.37% | 165 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| MiMedx Group | 808 |
| Entrada Therapeutics | 152 |
| Kyverna Therapeutics | 130 |
| Aura Biosciences | 113 |
| Verastem | 102 |
| Prothena Corporation | 67 |
| Tectonic Therapeutic | 60 |
| AgomAb Therapeutics NV | 58 |
RIGL News
- 6 days ago - Rigel Announces Conference Call and Webcast to Report First Quarter 2026 Financial Results - PRNewsWire
- 27 days ago - Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - PRNewsWire
- 4 weeks ago - Rigel Announces Publication of Final ARROW Clinical Trial Data on GAVRETO® (pralsetinib) in Patients with RET+ NSCLC in the Journal of Clinical Oncology - PRNewsWire
- 2 months ago - Rigel Pharmaceuticals Earnings Call Transcript: Q4 2025 - Transcripts
- 2 months ago - Rigel Provides Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - PRNewsWire
- 2 months ago - Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Full Year 2025 Financial Results and Business Update - PRNewsWire
- 3 months ago - Rigel Appoints Michael P. Miller to the Board of Directors - PRNewsWire
- 3 months ago - Rigel Pharmaceuticals Transcript: 44th Annual J.P. Morgan Healthcare Conference - Transcripts